PureTech Health (LON:PRTC) Stock Crosses Below 50-Day Moving Average – What’s Next?

PureTech Health plc (LON:PRTC) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 129.42 and traded as low as GBX 122. PureTech Health shares last traded at GBX 122.58, with a volume of 287,786 shares.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt restated a “buy” rating and set a GBX 508 target price on shares of PureTech Health in a report on Monday, December 8th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of GBX 508.

PureTech Health Trading Down 0.4%

The stock has a 50-day moving average of GBX 129.42 and a two-hundred day moving average of GBX 127.56. The company has a market cap of £295.65 million, a P/E ratio of 7.20 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.